FindTrial
Sign In

Safety and Efficacy of Ultrasound-Guided Liposomal Bupivacaine for Brachial Plexus Block via Costoclavicular Approach in Patients Undergoing Shoulder Arthroscopy

Safety and Efficacy of Ultrasound-Guided Liposomal Bupivacaine for Brachial Plexus Block via Costoclavicular Approach in Patients Undergoing Shoulder Arthroscopy"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093747
Enrollment
Unknown
Registered
2024-12-11
Start date
2025-01-01
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nerve block analgesia for shoulder arthroscopy

Interventions

Experimental Group (CCB Group):The experimental group received a brachial plexus block via the costoclavicular approach
Control Group (ISB Group):The control group received a brachial plexus block via the interscalene approach

Sponsors

The Second Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-70 years. 2. ASA (American Society of Anesthesiologists) Physical Status Classification System ?-?. 3. Patients scheduled for elective shoulder arthroscopy who consent to postoperative pain management using nerve block.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Combined with serious primary diseases such as lung, liver, kidney, cardiovascular and hematopoietic system; 3. Bleeding tendency or coagulation dysfunction; 4. Previous history of clavicle and neck surgery, nerve injury or neurological diseases; 5. History of allergy to local anesthetic drugs, skin infection at the puncture site or contraindications to block anesthesia in the concomitant area; 6. Previous history of neurological and psychiatric systems: history of craniocerebral injury, convulsions, epilepsy, intracranial hypertension, cerebrovascular accident; or schizophrenia, mania, long-term use of psychotropic drugs, history of cognitive dysfunction, etc., unable to read, understand and communicate; 7. Patients with obstructive or restrictive lung disease; 8. Obesity (BMI > 30kg/m2)

Design outcomes

Primary

MeasureTime frame
Incidence of hemidiaphragmatic paralysis 24 hours postoperatively;—

Secondary

MeasureTime frame
Ultrasound imaging time;Effective time and success rate;Mean NRS pain score at rest 24 hours after surgery;Postoperative adverse reactions;—

Countries

China

Contacts

Public ContactYao Yuanyuan

The Second Affiliated Hospital of Zhejiang University School of Medicine

305087422@qq.com+86 135 8887 2603

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026